Photodynamic therapy with meso-tetra(hydroxyphenyl) chlorin in the topical treatment of Bowen's disease and basal cell carcinoma

被引:0
|
作者
Gupta, G
Morton, CA
Whitehurst, C
Moore, JV
MacKie, RM
机构
[1] Univ Glasgow, Western Infirm, Dept Dermatol, Glasgow G11 6NT, Lanark, Scotland
[2] Christie Hosp, Paterson Inst Canc Res, Laser Oncol Programme, Canc Res Campaign,Sect Genome Damage & Repair, Manchester M20 4BX, Lancs, England
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:385 / 386
页数:2
相关论文
共 50 条
  • [1] Optimizing meso-tetra-hydroxyphenyl-chlorin-mediated photodynamic therapy for basal cell carcinoma
    Triesscheijn, Martijn
    Ruevekamp, Marjan
    Antonini, Ninja
    Neering, Herman
    Stewart, Fiona A.
    Baas, Paul
    PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2006, 82 (06) : 1686 - 1690
  • [2] Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis
    Shikowitz, MJ
    Abramson, AL
    Steinberg, BM
    DeVoti, J
    Bonagura, VR
    Mullooly, V
    Nouri, M
    Ronn, AM
    Inglis, A
    McClay, J
    Freeman, K
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2005, 131 (02) : 99 - 105
  • [3] COMPARISON OF THE PHOTOBLEACHING EFFECT OF 3 PHOTOSENSITIZING AGENTS - MESO-TETRA(M-HYDROXYPHENYL)CHLORIN, MESO-TETRA(M-HYDROXYPHENYL)PORPHYRIN AND PHOTOFRIN DURING PHOTODYNAMIC THERAPY
    MA, LW
    MOAN, J
    BERG, K
    LASERS IN MEDICAL SCIENCE, 1994, 9 (02) : 127 - 132
  • [4] In vivo photodynamic therapy with meso-tetra(m-hydroxyphenyl)chlorin (mTHPC): Influence of light intensity and optimization of photodynamic efficiency
    Rezzoug, H
    Aamar, O
    BarberiHeyob, M
    Merlin, JL
    Guillemin, F
    PHOTOCHEMOTHERAPY: PHOTODYNAMIC THERAPY AND OTHER MODALITIES II, PROCEEDINGS OF, 1996, 2924 : 181 - 186
  • [5] In vitro comparison of the photodynamic activity of meso-tetra (m-hydroxyphenyl) chlorin and hematoporphyrin derivative.
    Rezzoug, H
    BarberiHeyob, M
    Merlin, JL
    Bolotine, L
    Lignon, D
    Guillemin, F
    BULLETIN DU CANCER, 1996, 83 (10) : 816 - 822
  • [6] Photodynamic therapy for superficial basal cell carcinoma and Bowen's disease
    Clayton, TH
    Tait, J
    Whitehurst, C
    Yates, VM
    EUROPEAN JOURNAL OF DERMATOLOGY, 2006, 16 (01) : 39 - 41
  • [7] Photodynamic therapy with violet light and topical δ-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma
    Dijkstra, AT
    Majoie, IML
    van Dongen, JWF
    van Weelden, H
    van Vloten, WA
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2001, 15 (06) : 550 - 554
  • [8] Factors influencing pain in topical photodynamic therapy in the treatment of actinic keratosis, Bowen disease and basal cell carcinoma
    Hambly, R.
    Mansoor, N.
    Shah, Z.
    Quinlan, C.
    Ralph, N.
    Moloney, F. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 : 103 - 103
  • [9] Topical photodynamic therapy for primary Bowen disease and basal cell carcinoma: optimizing patient selection
    Hambly, R.
    Mansoor, N.
    Quinlan, C.
    Shah, Z.
    Lenane, P.
    Ralph, N.
    Moloney, F. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (03) : E55 - E57
  • [10] Factors predicting response to treatment and disease recurrence following topical photodynamic therapy for primary Bowen disease and basal cell carcinoma
    Hambly, R.
    Mansoor, N.
    Quinlan, C.
    Shah, Z.
    Ralph, N.
    Moloney, F. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 : 100 - 101